FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067484 [Registered on: 16/05/2024] Trial Registered Prospectively
Last Modified On: 10/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparing the effect of drug combinations Dexmedetomidine and Fentanyl with Midazolam and Fentanyl through intranasal route in children to make them calm and comfortable before surgery  
Scientific Title of Study   Comparison of premedication with intranasal Dexmedetomidine and Fentanyl combination with Midazolam and Fentanyl combination in children 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nishtha Vij 
Designation  PG Resident 
Affiliation  VMMC and Safdarjung Hospital  
Address  Department of Anaesthesia and Intensive Care, ground floor, main operation theatre building, Safdarjung Hospital, Ansari Nagar, New Delhi, Delhi

South West
DELHI
110029
India 
Phone  9718506789  
Fax    
Email  nishthavijd@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jeetendra Kumar Bajaj 
Designation  Professor and Consultant 
Affiliation  VMMC and Safdarjung Hospital  
Address  Department of Anaesthesia and Intensive Care, ground floor, main operation theatre building, Safdarjung Hospital, Ansari Nagar, New Delhi, Delhi

South West
DELHI
110029
India 
Phone  9810465070  
Fax    
Email  jeetendrabajaj@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nishtha Vij 
Designation  PG Resident 
Affiliation  VMMC and Safdarjung Hospital  
Address  Department of Anaesthesia and Intensive Care, ground floor, main operation theatre building, Safdarjung Hospital, Ansari Nagar, New Delhi, Delhi


DELHI
110029
India 
Phone  9718506789  
Fax    
Email  nishthavijd@gmail.com  
 
Source of Monetary or Material Support  
VMMC and Safdarjung Hospital,New Delhi, India -110015 
 
Primary Sponsor  
Name  Dr Nishtha Vij 
Address  Safdarjung Hospital, New Delhi, Delhi 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nishtha Vij  VMMC and Safdarjung Hospital  Department of Anaesthesiology and Intensive Care, ground floor, Mai n OT building Safdarjung Hospital Campus, Ansari Nagar, New Delhi, Delhi
South West
DELHI 
9718506789

nishthavijd@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Vardhman Mahavir Medical College and Safdarjung Hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Fentanyl and Dexmedetomidine   dose-Fentanyl-2mcg/kg, Dexmedetomidine-1 mcg/kg frequency-once before surgery route of administration- Intranasal total duration of intervention- (30-60)minutes 
Comparator Agent  Fentanyl and Midazolam  dose-Fentanyl-2mcg/kg, Midazolam-0.2mg/kg frequency-once before surgery route of administration- Intranasal total duration of intervention- (30-60)minutes 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  6.00 Year(s)
Gender  Both 
Details  All patients of age group (2-6) years ASA grade 1 undergoing elective surgery under general anesthesia with supraglottic airway device or endotracheal tube 
 
ExclusionCriteria 
Details  1. Patients with active upper airway disease
2. Patients with known allergy to study drug
3. Patients at risk for airway obstruction
4. Patients with neurodevelopmental delay 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To compare ease of parental separation in children undergoing elective surgery by premedication with intranasal combinations of Fentanyl and Dexmedetomidine with intranasal Fentanyl and Midazolam.  Parental separation assessed once at (30-60) minutes post drug intervention. 
 
Secondary Outcome  
Outcome  TimePoints 
Assessment of:
1. Preoperative sedation using 4 point sedation scale
2. Mask acceptance using mask acceptance scale
3. Post operative analgesia using FLACC Scale
4. Recovery profile 
1.Pre op sedation scale measured once at baseline pre-operatively.
2. Mask acceptance scale measured once at baseline during induction.
3.FLACC Scale measured post operatively at baseline, 15 minutes,30 minutes, 45 minutes, 60 minutes.
4. Recovery profile once post operatively. 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Premedication in children undergoing surgeries plays a pivotal role in alleviating anxiety, promote relaxation and facilitate smooth induction of anaesthesia. Various drugs have been used as premedication out of which Dexmedetomidine, a highly selective alpha 2  adrenoreceptor agonist has been increasingly used owing to its various benefits. Fentanyl is a synthetic opioid which acts on mu-opioid  receptors to produce analgesia. Midazolam is a benzodiazepam that causes sedation  , anterograde amnesia, and hypnosis by acting on GABA receptors on CNS. Here we are trying to compare intranasal drug combinations of Fentanyl  and Dexmedetomidine with Fentanyl and Midazolam as premedication in children aged 2-6 years  undergoing elective surgery under general anaesthesia. The methodology and  administration of drug shall be explained in detail with a written well informed consent from the parents. The children shall be divided into two groups of 30 each using block randomisation technique (Group I will receive intranasal Fentanyl 2mcg/kg and Dexmedetomidine 1 mcg/kg and Group II will receive Fentanyl 2mcg/kg and Midazolam 0.2 mg/kg) using mucosal atomising device. Patient will be taken to pre op room and baseline vitals shall be noted, child will be premedicated with allocated drug group and observed for 30-60 minutes , vital parameters and sedation score shall be noted then ease of parental separation shall be noted using appropriate scale. Patient shall be taken to ot, standard anaesthetic protocol shall be followed, sedation  score upon arrival and Mask acceptance score using appropriate scale, hemodynamic parameters shall be noted. After neuromuscular reversal, child will be shifted to post operative care unit and sedation score, FLACC Scale for postoperative pain and vital parameters shall be recorded every 15 minutes uptill 1 hour postoperatively. 
Close